Blepharitis Treatment Market Predicted to Witness Steady Growth by 2026


Posted February 27, 2019 by sagarj1030

The blepharitis treatment market is expected to witness significant grow due to growing prevalence of ophthalmic disorders among the geriatric population.

 
Blepharitis is a chronic condition that causes inflammation of the eyelids. Blepharitis usually affects the part of eyelid where eyelashes grow and occurs when tiny oil glands near this area are clogged, in turn causing irritation and redness of the eyes. Symptoms of blepharitis include high sensitivity to light, loss of eyelashes, watery eyes, burning sensation in the eyes, greasy eyelids, itchy eyes, red and swollen eyes, flaking of skin around the eyes, crusted eyelashes after waking up, more frequent blinking, abnormal growth of eyelashes, and stinging sensation in the eyes. Blepharitis causes seborrheic dermatitis, which is dandruff of the eyebrows and scalp, bacterial infection, clogged oil glands, malfunctioning of oil glands, rosacea. It also causes allergic reactions to eye medications, contact lens solutions or eye make-up and eyelash lice or mites.

Ask For In-Depth Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1761

Blepharitis Treatment Market Drivers:-

The blepharitis treatment market is expected to witness significant grow due to growing prevalence of ophthalmic disorders among the geriatric population. According to a survey conducted by American Academy of Ophthalmology in 2014, blepharitis usually affects people above the age of 50 years. It also states that blepharitis is observed in 37% male ophthalmic patients and 47% in female ophthalmic patients. Blepharitis market is also expected to grow due to increasing number of drugs in the pipeline. For instance, ISV-305 sponsored by InSite Vision is in phase 3 clinical trials, ISV-305 treats patients with early symptoms of blepharitis. Furthermore, new product launches and mergers and acquisitions over the recent past also contributes to market growth. For instance, in 2015, BlephEx, a Franklin-based company launched Rysurg. It is used to clean eyelids and also maintains hygiene. According to a study conducted by American Academy of Ophthalmology in 2015 around 50% of ophthalmic patients suffer from symptoms of blepharitis and dry eyes. Constant use of this device helps prevent recurrence of blephairis and the treatment is pain-free.

Blepharitis Treatment Market Regional Analysis:-

North America Blepharitis treatment market is expected to hold dominant position due to increasing geriatric population, launch of new products, and increasing number of ophthalmic patients in the region. According to a survey conducted in the U.S., by Population Reference Bureau in 2016, states that the aging population increased by 24% as compared to 15% in 2014. Europe is expected to witness rapid growth due to new product launches of blepharitis drugs in the region. For instance, in 2017, Scope Ophthalmic launched Moist Heat Mask, a device that helps in the treatment of blepharitis by loosening the oil present in Meibomian glands and allowing it to flow more freely. It helps to soften eye lash debris, prevent the evaporation of natural tear film, restores moisture to the eye and also the surrounding area, as well as improves tear film lipid quality.

Blepharitis Treatment Market Key Players:-

Key players operating in the Blepharitis treatment market include Scope Ophthalmic Ltd, NovaBay Pharmaceuticals Inc, Thea Pharmaceuticals Ltd, Perrigo Laboratories, InSite Vision Incorporated, Merck & Co, and Novartis AG

Blepharitis Treatment Market Taxonomy:-
The global Blepharitis treatment market is segmented based on disease type, treatment type, distribution channel, and region.

By Disease Type:-
Posterior Blepharitis
Anterior Blepharitis
Mixed Blepharitis
By Treatment Type:-
Antibiotic Therapy
Topical Corticosteroids
Topical Antibodies
Oral Antibodies
Ointments
Eye Cleansers
Others
By Distribution Channel:-
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:-
North America
Europe
Latin America
Asia-Pacific
Middle East
Africa

Browse Complete Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/blepharitis-treatment-market-1761

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Coherent Market Insights
Country United States
Categories Health
Tags blepharitis treatment market , blepharitis treatment market analysis , blepharitis treatment market growth
Last Updated February 27, 2019